Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Impact of switching from bisphosphonates to denosumab, te... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study
0
Authors
Toshitaka Yukishima
7 more
Toshitaka Yukishima
•
Kosuke Ebina
5 more
•
Tomonori Kobayakawa
Published
January 16, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Osteoporosis International
Topics
Medicine
Cancer Oncology
Internal Medicine
Orthopedics And Sports Medicine
Molecular Biology
Show all topics
DOI
10.1007/s00198-025-07386-4
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Osteoporosis International
Topics
Medicine
Cancer Oncology
Internal Medicine
Orthopedics And Sports Medicine
Molecular Biology
Show all topics
DOI
10.1007/s00198-025-07386-4
License
CC-BY-NC
